Pharming Group is a biopharmaceutical company based in the Netherlands that develops and commercialises medicines for rare and serious diseases. Its main product is a treatment for hereditary angioedema, a genetic disorder that causes sudden swelling attacks, and it also works on therapies for other rare conditions. The company serves patients and specialist physicians, mainly in Europe and North America, through its own commercial teams and partners.
The shares are listed on the Euronext Amsterdam in Netherlands under the code PHARM, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #94 of 109 on the Euronext Amsterdam · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Netherlands yet.
TrendWeak
17/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-9.2%
From 52-week high-39.3%
MomentumWeak
23/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-4.4%
6-month return-24.2%
12-month, skipping last month-19.9%
Stability (higher is calmer)Weak
8/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)60.1%
Worst drawdown, 1 year (smaller is calmer)-53.5%
LiquidityFair
70/100
Moderate trading activity.
See the numbers →
Avg daily value traded7.69M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Netherlands when fundamentals data for this market is added. All Netherlands stocks.
52-wk range 0.820 – 1.818Daily closes, split-adjusted
Signals
50-day average0.932
200-day average1.189
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.042
Technical summary
Daily
Bullish
10 bullish · 0 neutral · 6 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
0.92
Bullish
EMA 10
0.95
Bullish
SMA 20
0.89
Bullish
EMA 20
0.92
Bullish
SMA 50
0.93
Bullish
EMA 50
0.94
Bullish
SMA 100
1.02
Bullish
EMA 100
1.01
Bullish
SMA 200
1.19
Bearish
EMA 200
1.09
Bearish
Oscillators (daily)
RSI (14)
74.23
Bearish
MACD (12, 26)
0.02
Bullish
Momentum (12)
23.23
Bullish
Stochastic %K (14)
90.28
Bearish
Williams %R (14)
-9.72
Bearish
CCI (20)
261.0
Bearish
Pivot points (classic, last session)
S3
0.99
S2
1.02
S1
1.05
Pivot
1.08
R1
1.11
R2
1.14
R3
1.17
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
